Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Dangerous glucose-hungry cervical tumors can be detected using PET scans

03.04.2006


Cervical cancers that take up a lot of blood sugar, or glucose, are more resistant to treatment than those that are less glucose-hungry, according to research at Washington University School of Medicine in St. Louis. The researchers also found that the high glucose-uptake tumors can be identified with PET scans, which are already routinely used to determine tumor size and lymph node involvement in cervical cancer patients.



PET scans monitor the amount of a radioactive glucose tracer absorbed by cells, so the brightness of the image reveals how much glucose a tumor takes up. The results of the research team’s analysis indicate that PET scans can be used to better determine prognosis in cervical cancer patients.

"Cervical tumors vary more in their glucose uptake than other kinds of cancer, making glucose uptake a very useful indicator for cervical cancers," says Perry W. Grigsby, M.D., a radiation oncologist with the Siteman Cancer Center at Washington University School of Medicine and Barnes-Jewish Hospital. "We found that the tumors with higher uptake were associated with lower survival rates and lower disease-free survival rates."


In a report published in the April issue of Gynecological Oncology, the researchers summarized their findings for 96 cervical cancer patients who underwent PET scans before radiation and chemotherapy were initiated.

Analysis showed that 71 percent of patients whose tumors had a glucose uptake value below the median value of 10.2 survived five years without a recurrence of their disease. In contrast, 52 percent of those whose glucose uptake measured above 10.2 went for five years without a recurrence.

Since submitting their findings, the team has continued their investigation with additional patients, who now number near 250. The trend of lower five-year disease-free survival with higher tumor glucose uptake has been born out in the additional patients.

Further, the continuing study has clearly demonstrated that the overall (disease-free and disease-recurring) five-year survival rate was lower in the group of patients whose tumor glucose uptake was above the median of 10.2.

"Our clinical experience has taught us that standard therapy, which includes both chemotherapy with cisplatin and radiation treatments, doesn’t seem to be able to cure these cancers if their glucose metabolism is high," says Grigsby, professor of radiation oncology, of nuclear medicine and of obstetrics and gynecology. "We don’t yet know what therapy will be more effective in these cases. For the time being, we’re closely watching the response of the tumor to treatment and surgically removing the tumor and surrounding tissue when necessary."

To improve treatment options in the future, Grigsby is initiating a study to uncover the cellular mechanisms that are altered in tumors that uptake a lot of glucose.

"I’ve looked at the proteins that transport glucose into tumor cells, and I haven’t seen any significant differences between the glucose transporters in tumors with high glucose uptake and those with low glucose uptake," Grigsby says. "So we’re taking a different approach.

We’re going to biopsy tumors over the course of treatment. Then we’ll look for which genes change activity during treatment. If we can find predictable changes, they may lead us to better treatments for the more-resistant cervical tumors."

Gwen Ericson | EurekAlert!
Further information:
http://www.wustl.edu

More articles from Health and Medicine:

nachricht Study tracks inner workings of the brain with new biosensor
16.08.2018 | Rheinische Friedrich-Wilhelms-Universität Bonn

nachricht Foods of the future
15.08.2018 | Georg-August-Universität Göttingen

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Color effects from transparent 3D-printed nanostructures

New design tool automatically creates nanostructure 3D-print templates for user-given colors
Scientists present work at prestigious SIGGRAPH conference

Most of the objects we see are colored by pigments, but using pigments has disadvantages: such colors can fade, industrial pigments are often toxic, and...

Im Focus: Unraveling the nature of 'whistlers' from space in the lab

A new study sheds light on how ultralow frequency radio waves and plasmas interact

Scientists at the University of California, Los Angeles present new research on a curious cosmic phenomenon known as "whistlers" -- very low frequency packets...

Im Focus: New interactive machine learning tool makes car designs more aerodynamic

Scientists develop first tool to use machine learning methods to compute flow around interactively designable 3D objects. Tool will be presented at this year’s prestigious SIGGRAPH conference.

When engineers or designers want to test the aerodynamic properties of the newly designed shape of a car, airplane, or other object, they would normally model...

Im Focus: Robots as 'pump attendants': TU Graz develops robot-controlled rapid charging system for e-vehicles

Researchers from TU Graz and their industry partners have unveiled a world first: the prototype of a robot-controlled, high-speed combined charging system (CCS) for electric vehicles that enables series charging of cars in various parking positions.

Global demand for electric vehicles is forecast to rise sharply: by 2025, the number of new vehicle registrations is expected to reach 25 million per year....

Im Focus: The “TRiC” to folding actin

Proteins must be folded correctly to fulfill their molecular functions in cells. Molecular assistants called chaperones help proteins exploit their inbuilt folding potential and reach the correct three-dimensional structure. Researchers at the Max Planck Institute of Biochemistry (MPIB) have demonstrated that actin, the most abundant protein in higher developed cells, does not have the inbuilt potential to fold and instead requires special assistance to fold into its active state. The chaperone TRiC uses a previously undescribed mechanism to perform actin folding. The study was recently published in the journal Cell.

Actin is the most abundant protein in highly developed cells and has diverse functions in processes like cell stabilization, cell division and muscle...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

LaserForum 2018 deals with 3D production of components

17.08.2018 | Event News

Within reach of the Universe

08.08.2018 | Event News

A journey through the history of microscopy – new exhibition opens at the MDC

27.07.2018 | Event News

 
Latest News

Smallest transistor worldwide switches current with a single atom in solid electrolyte

17.08.2018 | Physics and Astronomy

Robots as Tools and Partners in Rehabilitation

17.08.2018 | Information Technology

Climate Impact Research in Hannover: Small Plants against Large Waves

17.08.2018 | Life Sciences

VideoLinks
Science & Research
Overview of more VideoLinks >>>